title: Metabolism of [3H]equilin-[35S]sulfate and [3H]equilin sulfate after oral and intravenous administration in normal postmenopausal women and men.
abstract: The absorption of equilin sulfate and equilin from the gastrointestinal tract was determined in normal men after the ingestion of [3H]equilin-[35S]sulfate or a mixture of [3H]equilin and equilin-[35S]sulfate, while the metabolism of equilin sulfate was investigated after iv administration of [3H]equilin sulfate to postmenopausal women. After the oral administration of [3H]equilin-[35S]sulfate, equilin sulfate containing both 3H and 35S was isolated from plasma; however, only in the first sample taken at 10 min was the 3H/35S ratio the same as that of the [3H]equilin-[35S]sulfate ingested. The 3H/35S ratio then increased, and by 12 h only traces of equilin-[35S]sulfate were detectable. Similarly, after the ingestion of [3H]equilin and equilin-[35S]sulfate, [3H]equilin-[35S]sulfate was isolated from plasma. The 3H/35S ratio was at all time points greater than the 3H/35S ratio of the ingested mixture. Analysis of urine indicated that over 98% of 35S was not associated with any steroid and was most likely inorganic sulfate. After iv administration of [3H] equilin sulfate to postmenopausal women, equilin, equilenin, 17 beta-dihydroequilin, and 17 beta-dihydroequilenin were isolated from the urine. These results indicate that 1) some of the orally administered equilin sulfate was absorbed from the gut without prior hydrolysis, 2) some equilin sulfate was hydrolyzed in the gut before absorption; 3) equilin was absorbed more efficiently than equilin sulfate; 4) equilin absorbed was readily sulfated and circulated in this form; and 5) equilin sulfate was extensively metabolized, and the metabolites were excreted in the urine mainly conjugated with glucuronic acid.
authors.affiliation: Reproductive Biology Research Program, McMaster University, Hamilton, Ontario, Canada.
authors.forename: B R
authors.initials: BR
authors.lastname: Bhavnani
authors.forename: C A
authors.initials: CA
authors.lastname: Woolever
authors.forename: D
authors.initials: D
authors.lastname: Wallace
authors.forename: C C
authors.initials: CC
authors.lastname: Pan
mesh_terms: D015068:17-Ketosteroids / Q000378:metabolism*; D000284:Administration, Oral; D000367:Age Factors; D004064:Digestive System / Q000378:metabolism; D004855:Equilenin / Q000031:analogs & derivatives / Q000652:urine; D004857:Equilin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008297:Male; D008593:Menopause; D008875:Middle Aged
chemical_list: D015068:17-Ketosteroids; D004857:Equilin; C037874:17-dihydroequilenin; C014482:dihydroequilin; C037875:equilin sulfate; D004855:Equilenin